Bert van Geel

Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a<i>BRCA1</i>or<i>BRCA2</i>Mutation

Hanne Meijers-Heijboer, Bert van Geel, Wim L.J. van Putten et al. · New England Journal of Medicine · 2001 · 963 citations · Full text

Medicine, Oncology, Surgery +12

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a <i>BRCA1</i> or <i>BRCA2</i> Mutation

Hanne Meijers-Heijboer, Cecile T.M. Brekelmans, Marian B. E. Menke‐Pluymers et al. · Journal of Clinical Oncology · 2003 · 119 citations

Medicine, Gynecology, Oncology +15

Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

Mieke Kriege, Caroline Seynaeve, Hanne Meijers-Heijboer et al. · Journal of Clinical Oncology · 2009 · 103 citations · Full text

Medicine, Oncology, Pharmacology +15

Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients

Mieke Kriege, Caroline Seynaeve, Hanne Meijers‐Heijboer et al. · Breast Cancer Research and Treatment · 2007 · 35 citations

Medicine, Oncology, Breast Oncology +15

Reasons for non-entry of patients with DCIS of the breast into a randomised trial (EORTC 10853)

I S Fentiman, Jean‐Pierre Julien, J.A. van Dongen et al. · European Journal of Cancer and Clinical Oncology · 1991 · 19 citations

Medicine, Oncology, Surgery +6